Significance of chemokines and activated platelets in patients with diabetes

Clinical and Experimental Immunology

Volumn 121, Issue 3, 2000, Pages 437-443

  Nomura, S ^a   Shouzu, A ^a   Omoto, S ^a   Nishikawa, M ^a   Fukuhara, S ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemokine; Diabetes; P selectin; Platelet derived microparticle; Ticlopidine

Indexed keywords

CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 8; LIPOCORTIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES; TICLOPIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; VASCULAR DISEASE;

ADULT; ANNEXIN A5; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; E-SELECTIN; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; RANTES; TICLOPIDINE;

EID: 0033857835     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01324.x     Document Type: Article

References (47)

1. Mortality and survival in type 2 (non-insulin dependent) diabetes
2. International comparisons of IDDM mortality
3. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates
4. The hypercoagulable states
5. Diabetes as a hypercoagulable state: Its relationship with fibrin fragments and vascular damage
6. Platelet function in diabetes
7. Direct detection of activated platelets and platelet-derived microparticles in humans
8. Large platelets circulate in an activated state in diabetes
9. Isolation of human platelet membrane microparticles from plasma and serum
10. Complement proteins C5b9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity
11. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease
12. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes
13. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
14. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation
15. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM-1, and E-selectin in human atheroscrelosis
16. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes are independent of glycaemic control
17. Macrophages in acute glomerular inflammation
18. The role of macrophages in diabetic glomerulosclerosis
19. Cytokine-activated human endothelial cells synthesize and secrete a monochemoattractant, MCP-1/JE
20. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes
21. A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells
22. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokine
23. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils
24. Differences between platelet and microparticle glycoprotein IIb/IIIa
25. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation
26. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry
27. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody
28. Platelet abnormalities in diabetes
29. The role of platelets in the development and complications of atherosclerosis
30. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets
31. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease
32. Macrophage inflammatory protein-1: A novel chemokine cytokine for macrophages in rheumatoid arthritis
33. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
34. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
35. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection
36. Activated platelets signal chemokine synthesis by human monocytes
37. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets
38. A systematic overview of randomized trials of antiplatelet agents for the prevention of stroke, myocardial infarction, and vascular death
39. Diabetes
40. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response
41. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles
42. Thrombin induces platelet adhesion to endothelial cells
43. Adhesion receptors of the immune system
44. Endothelial-leukocyte adhesion molecules
45. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes
46. Study on the interference of ticlopidine on the immune system
47. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation